Theranica Wins FDA Approval for Its Wearable Nerivio to Treat Acute Migraine in Adolescents

By
Sam Draper
-
Theranica Nerivio FDA approval
PRNewswire
Theranica, a prescribed digital therapeutics (PDT) company developing advanced electroceuticals for migraine and other pain conditions, announced that its Nerivio therapeutic device has received the Food and Drug Administration clearance […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleAktiia® Receives CE Mark Approval for Breakthrough 24-7 Blood Pressure Monitoring System
Next articleHuawei Focuses On Health Care Wearables As It Pushes Into New Growth Areas
Sam Draper
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.

RELATED ARTICLESMORE FROM AUTHOR